Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2007-2-9
pubmed:abstractText
The goal of this study was to evaluate the efficacy of 100% oxygen and inhaled nitric oxide (iNO) in decreasing pulmonary vascular resistance (PVR) and transpulmonary gradient (TPG) in dilated cardiomyopathy patients being evaluated for orthotopic heart transplantation (OHT); who, despite maximal intravenous (IV) dilator therapy, had persistent moderate-to-severe pulmonary hypertension.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1053-0770
pubmed:author
pubmed:issnType
Print
pubmed:volume
21
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
51-6
pubmed:meshHeading
pubmed-meshheading:17289480-Adult, pubmed-meshheading:17289480-Aged, pubmed-meshheading:17289480-Blood Pressure, pubmed-meshheading:17289480-Cardiomyopathy, Dilated, pubmed-meshheading:17289480-Endothelium-Dependent Relaxing Factors, pubmed-meshheading:17289480-Female, pubmed-meshheading:17289480-Heart Transplantation, pubmed-meshheading:17289480-Humans, pubmed-meshheading:17289480-Hypertension, Pulmonary, pubmed-meshheading:17289480-Male, pubmed-meshheading:17289480-Middle Aged, pubmed-meshheading:17289480-Nitric Oxide, pubmed-meshheading:17289480-Oxygen, pubmed-meshheading:17289480-Preoperative Care, pubmed-meshheading:17289480-Prospective Studies, pubmed-meshheading:17289480-Pulmonary Artery, pubmed-meshheading:17289480-Stroke Volume, pubmed-meshheading:17289480-Treatment Outcome, pubmed-meshheading:17289480-Vascular Resistance, pubmed-meshheading:17289480-Ventricular Function, Right
pubmed:year
2007
pubmed:articleTitle
Inhaled nitric oxide in the preoperative evaluation of pulmonary hypertension in heart transplant candidates.
pubmed:affiliation
Department of Anesthesiology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095, USA. amahajan@mednet.ucla.edu
pubmed:publicationType
Journal Article, Clinical Trial